Search By Initial

Name Index A

• Aleglitazar (Catalog# : 193125, Cas# : 475479-34-6)Aleglitazar, also known as RG-1439 or RO-0728804, is a peroxisome proliferator-activa
• Alvimopan (Catalog# : 19382, Cas# : 156053-89-3)Alvimopan, also known as HSDB-7704 and LY246736, is a drug which behaves as a periphe
• Abrocitinib (Catalog# : 19381, Cas# : 1622902-68-4)Abrocitinib, Bulk in stock, contact us by email for the quotation. Kg scale intermedi
• AA26-9 (Catalog# : 19372, Cas# : 1312782-34-5)AA26-9 is a potent and broad-spectrum serine hydrolase inhibitor. AA26-9-inhibited en
• AZD-0284 (Catalog# : 19365, Cas# : 2101291-07-8)AZD-0284 is a potent, selective, inverse agonist of the nuclear receptor RORγ for th
• AZ304 (Catalog# : 19363, Cas# : 942507-42-8)AZ304 is an ATP-competitive dual BRAF kinase inhibitor, potently inhibits wild type B
• AZ876 (Catalog# : 19356, Cas# : 898800-26-5)AZ876, also known as AZ-876, is a liver X receptor agonist. AZ876 protects against pa
• AGN-190299 (Catalog# : 19316, Cas# : 118292-41-4)Tazarotene is a retinoid prodrug which is converted to its active form, the cognate c
• AM281 (Catalog# : 19315, Cas# : 202463-68-1)AM281 is a synthetic cannabinoid CB1 receptor antagonist.
• ASP9521 (Catalog# : 19312, Cas# : 1126084-37-4)ASP9521 is a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid d
• AZD0364 (Catalog# : 192275, Cas# : 2097416-76-5)AZD0364 is an ERK1 and/or ERK2 kinase for the treatment of cancer. ERK1 and ERK2 kina
• ATF6-activator-147 (Catalog# : 192212, Cas# : 393121-74-9)ATF6-activator-147 is an ATF6 simulator which acts as a prodrug that preferentially t
• AZD1152 (Catalog# : 192156, Cas# : 722543-31-9)AZD1152 is a pro-drug of Barasertib-hQPA, which is a highly selective Aurora B inhibi
• AZD3229 (Catalog# : 191287, Cas# : 2248003-60-1)AZD3229 is a potent pan-KIT mutant inhibitor for the treatment of gastrointestinal st
• AM095 sodium (Catalog# : 191251, Cas# : 1345614-59-6)AM095 is a potent LPA1 receptor antagonist because it inhibited GTPγS binding to Chi
• AZD4573 free base (Catalog# : 191212, Cas# : 2057509-72-3)AZD-4573 is a selective, short-acting inhibitor of the serine/threonine cyclin-depend
• AR-9281 (Catalog# : 191146, Cas# : 913548-29-5)AR-9281 is a soluble epoxide hydrolase (s-EH) inhibitor potentially for the treatment
• ARRY-797 (ARRY-371797) (Catalog# : 191112, Cas# : 1036404-17-7)ARRY-797 is an oral, selective p38 mitogen-activated protein kinase inhibitor. ARRY-7
• Abivertinib (Catalog# : 19141, Cas# : 1557267-42-1)Abivertinib, also known as AC0010 and Avitinib, is a tyrosine kinase inhibitor, antin
• AZD7507 (Catalog# : 1812294, Cas# : 1041852-85-0)AZD7507 is a potent and selective CSF-1R inhibitor (32 nM cell activity), AZD7507 is
• Auranofin (Catalog# : 1812281, Cas# : 34031-32-8)Auranofin, also known as Ridaura and SKF-39162, is an oral chrysotherapeutic agent fo
• AX-024 HCl (Catalog# : 181254, Cas# : 1704801-24-0)AX-024 is an orally available inhibitor of the TCR-Nck interaction that selectively i
• AG 879 (Catalog# : 1811303, Cas# : 148741-30-4)AG-879 is a tyrphostin compound that inhibits nerve growth factor-dependent TrkA tyro
• Avagacestat (Catalog# : 1811283, Cas# : 1146699-66-2)Avagacestat, also known as BMS-708163, is an oral GSI designed for selective inhibiti
• AS1842856 (Catalog# : 1811265, Cas# : 836620-48-5)AS1842856 is a cell-permeable Foxo1inhibitor that blocks the transcription activity o
• Anlotinib HCl ( AL-3818 ) (Catalog# : 1811211, Cas# : 1360460-82-7)Anlotinib is a novel oral tyrosine kinase inhibitor (TKI) targeting c-kit, platelet-d
• Avatrombopag maleate (Catalog# : 5141902, Cas# : 677007-74-8)Avatrombopag maleate is an orally bioavailable, small molecule thrombopoietin recepto
• AZD-3514 (Catalog# : 1810251, Cas# : 1240299-33-5)AZD-3514 is a potent androgen receptor downregulator with potential anticancer cancer
• AZ32 (Catalog# : 1810223, Cas# : no)AZ32 is an orally bioavailable and blood-brain barrier-penetrating ATM inhibitor with
• ARS-1620 (Catalog# : 1810222, Cas# : 1698055-85-4)ARS-1620 is an atropisomeric selective KRAS-G12C inhibitor with desirable pharmacokin